These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 22773152)
1. Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease. Pastano R; Dell'Agnola C; Bason C; Gigli F; Rabascio C; Puccetti A; Tinazzi E; Cetto G; Peccatori F; Martinelli G; Lunardi C Int Immunol; 2012 Sep; 24(9):583-91. PubMed ID: 22773152 [TBL] [Abstract][Full Text] [Related]
2. Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach. Lunardi C; Dolcino M; Peterlana D; Bason C; Navone R; Tamassia N; Beri R; Corrocher R; Puccetti A PLoS Med; 2006 Jan; 3(1):e2. PubMed ID: 16318412 [TBL] [Abstract][Full Text] [Related]
3. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Lunardi C; Bason C; Navone R; Millo E; Damonte G; Corrocher R; Puccetti A Nat Med; 2000 Oct; 6(10):1183-6. PubMed ID: 11017152 [TBL] [Abstract][Full Text] [Related]
4. Generation of anti-NAG-2 mAb from patients' memory B cells: implications for a novel therapeutic strategy in systemic sclerosis. Traggiai E; Lunardi C; Bason C; Dolcino M; Tinazzi E; Corrocher R; Puccetti A Int Immunol; 2010 May; 22(5):367-74. PubMed ID: 20207716 [TBL] [Abstract][Full Text] [Related]
5. IgG antibodies to human cytomegalovirus late protein UL94 in patients with systemic sclerosis. Namboodiri AM; Rocca KM; Pandey JP Autoimmunity; 2004 May; 37(3):241-4. PubMed ID: 15497459 [TBL] [Abstract][Full Text] [Related]
8. Induction of endothelial cell damage by hCMV molecular mimicry. Lunardi C; Bason C; Corrocher R; Puccetti A Trends Immunol; 2005 Jan; 26(1):19-24. PubMed ID: 15629405 [TBL] [Abstract][Full Text] [Related]
9. A Paradigmatic Interplay between Human Cytomegalovirus and Host Immune System: Possible Involvement of Viral Antigen-Driven CD8+ T Cell Responses in Systemic Sclerosis. Arcangeletti MC; Maccari C; Vescovini R; Volpi R; Giuggioli D; Sighinolfi G; De Conto F; Chezzi C; Calderaro A; Ferri C Viruses; 2018 Sep; 10(9):. PubMed ID: 30231575 [TBL] [Abstract][Full Text] [Related]
10. Human cytomegalovirus (HCMV) UL44 and UL57 specific antibody responses in anti-HCMV-positive patients with systemic sclerosis. Marou E; Liaskos C; Simopoulou T; Efthymiou G; Dardiotis E; Katsiari C; Scheper T; Meyer W; Hadjigeorgiou G; Bogdanos DP; Sakkas LI Clin Rheumatol; 2017 Apr; 36(4):863-869. PubMed ID: 28124759 [TBL] [Abstract][Full Text] [Related]
11. Infections and autoimmunity: role of human cytomegalovirus in autoimmune endothelial cell damage. Dolcino M; Puccetti A; Barbieri A; Bason C; Tinazzi E; Ottria A; Patuzzo G; Martinelli N; Lunardi C Lupus; 2015 Apr; 24(4-5):419-32. PubMed ID: 25801885 [TBL] [Abstract][Full Text] [Related]
12. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis. Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238 [TBL] [Abstract][Full Text] [Related]
13. A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT). Zikos P; Van Lint MT; Lamparelli T; Gualandi F; Occhini D; Mordini N; Berisso G; Bregante S; Bacigalupo A Haematologica; 1998 Feb; 83(2):132-7. PubMed ID: 9549924 [TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192 [TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus-induced CD13-specific autoimmunity--a possible cause of chronic graft-vs-host disease. Soderberg C; Larsson S; Rozell BL; Sumitran-Karuppan S; Ljungman P; Moller E Transplantation; 1996 Feb; 61(4):600-9. PubMed ID: 8610388 [TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin GM genes and IgG antibodies to cytomegalovirus in patients with systemic sclerosis. Pandey JP Clin Exp Rheumatol; 2004; 22(3 Suppl 33):S35-7. PubMed ID: 15344596 [TBL] [Abstract][Full Text] [Related]
17. The Mexican schedule to conduct allogeneic stem cell transplantation is related to a low risk of cytomegalovirus reactivation and disease. Ruiz-Argüelles GJ; Rangel JD; Ponce-de-León S; González-Déctor L; Reyes-Núñez V; Garcés-Eisele J Am J Hematol; 2004 Apr; 75(4):200-4. PubMed ID: 15054809 [TBL] [Abstract][Full Text] [Related]
18. Human Cytomegalovirus Protein UL94 Targets MITA to Evade the Antiviral Immune Response. Zou HM; Huang ZF; Yang Y; Luo WW; Wang SY; Luo MH; Fu YZ; Wang YY J Virol; 2020 Jun; 94(12):. PubMed ID: 32238587 [TBL] [Abstract][Full Text] [Related]
19. Allograft inflammatory factor-1 is overexpressed and induces fibroblast chemotaxis in the skin of sclerodermatous GVHD in a murine model. Yamamoto A; Ashihara E; Nakagawa Y; Obayashi H; Ohta M; Hara H; Adachi T; Seno T; Kadoya M; Hamaguchi M; Ishino H; Kohno M; Maekawa T; Kawahito Y Immunol Lett; 2011 Mar; 135(1-2):144-50. PubMed ID: 21040744 [TBL] [Abstract][Full Text] [Related]
20. Antibodies to human cytomegalovirus protein UL83 in systemic sclerosis. Namboodiri AM; Rocca KM; Kuwana M; Pandey JP Clin Exp Rheumatol; 2006; 24(2):176-8. PubMed ID: 16762154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]